Meridian Biosciences

The device, available for license from the Lawrence Livermore National Laboratories Industrial Partnerships Office, integrates a single-tube nucleic acid extraction method with loop-mediated isothermal amplification or reverse transcriptase LAMP.

Asuragen, Life Tech launch BCR/ABL1 Quant test in Europe; Palex Medical to distribute Molecular Detection’s MRSA assay in Spain; Meridian Biosciences gets FDA nod for C. difficile molecular amplification assay.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.